CHARACTERIZATION OF OCS USE IN PATIENTS STARTING BIOLOGICS FOR ASTHMA IN THE UNITED STATES

被引：0
|
作者：
Harvey, J. [1 ]
Zhang, S. [1 ]
Mu, G. [1 ]
Valliant, S. [1 ]
Alfonso-Cristancho, R. [1 ]
机构：
[1] GSK, Collegeville, PA USA
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CO34
引用
收藏
页码：S20 / S20
页数：1
相关论文
共 50 条
  • [1] Characterization of OCS Use Among Patients With Physician-Assigned Asthma and/or COPD in NOVELTY
    Janson, C.
    Muellerova, H.
    Belton, L.
    Rusibamayila, N.
    Erhard, C.
    Papi, A.
    Hughes, R.
    Quinton, A.
    McIvor, A.
    Chipps, B.
    Reddel, H. K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [2] Persistent Reductions in OCS Use in Patients with Severe, OCS-Dependent Asthma Treated with Dupilumab: LIBERTY ASTHMA TRAVERSE Study
    Gurnell, M.
    Ribas, C. Domingo
    Rabe, K. F.
    Menzies-Gow, A.
    Price, D.
    Brusselle, G.
    Wechsler, M. E.
    Xia, C.
    Djandji, M.
    Gall, R.
    Jacob-Nara, J. A.
    Rowe, P. J.
    Deniz, Y.
    Siddiqui, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [3] Persistent reductions in OCS use in patients with severe, OCS-dependent asthma treated with dupilumab: LIBERTY -ASTHMA TRAVERSE study
    Gurnell, M.
    Domingo, C.
    Rabe, K. F.
    Menzies-Gow, A.
    Price, D.
    Brusselle, G.
    Wechsler, M. E.
    Xia, C.
    Djandji, M.
    Gall, R.
    Jacob-Nara, J. A.
    Rowe, P. J.
    Deniz, Y.
    Siddiqui, S.
    ALLERGOLOGIE, 2022, 45 (08) : 610 - 611
  • [4] Dupilumab reduces OCS use and improves lung function in patients with severe OCS-dependent asthma
    Gurnell, M.
    Domingo, C.
    Rabe, K. F.
    Menzies-Gow, A.
    Price, D.
    Brusselle, G.
    Wechsler, M. E.
    Xia, C.
    Pandit-Abid, N.
    Gall, R.
    Jacob-Nara, J. A.
    Rowe, P. J.
    Deniz, Y.
    Siddiqui, S.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [5] Employment among Patients Starting Dialysis in the United States
    Erickson, Kevin F.
    Zhao, Bo
    Ho, Vivian
    Winkelmayer, Wolfgang C.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2018, 13 (02): : 265 - 273
  • [6] DUPILUMAB REDUCED OCS USE IN ASTHMA PATIENTS ACROSS BASELINE CHARACTERISTICS
    Castro, M.
    Hanania, N.
    Daizadeh, N.
    Ortiz, B.
    Pandit-Abid, N.
    Deniz, Y.
    Rowe, P.
    RESPIROLOGY, 2021, 26 : 40 - 40
  • [7] Trends and Disparities in Asthma Biologic Use in the United States
    Inselman, Jonathan W.
    Jeffery, Molly M.
    Maddux, Jacob T.
    Shah, Nilay D.
    Rank, Matthew A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (02): : 549 - +
  • [8] OCS use in uncontrolled severe asthma in Canada
    Cote, Andreanne
    Beach, Jeffrey
    Reynolds, Jenna
    Usuba, Koyo
    Tusin, Joshua
    Tehrani, Ali
    Jayakumar, Muthu K. G.
    Han, Tim Tian Yu
    Waserman, Susan
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [9] Dupilumab sustains improvements in clinical efficacy and reductions in OCS use in patients with severe, OCS-dependent asthma: LIBERTY ASTHMA TRAVERSE study
    Park, Hye Yun
    Gurnell, Mark
    Domingo, Christian
    Rabe, Klaus F.
    Menzies-Gow, Andrew
    Price, David
    Brusselle, Guy
    Wechsler, Michael E.
    Xia, Changming
    Pandit-Abid, Nami
    Gall, Rebecca
    Jacob-Nara, Juby A.
    Rowe, Paul J.
    Deniz, Yamo
    Siddiqui, Shahid
    RESPIROLOGY, 2023, 28 : 20 - 22
  • [10] REGIONAL VARIATION IN OCS USE FOR UK PATIENTS WITH ASTHMA: HEAT MAP ANALYSIS
    Menzies-Gow, A.
    Haslam, T.
    Morris, T.
    Gylvin, L. H.
    Bleecker, E. R.
    Nan, C.
    THORAX, 2019, 74 : A169 - A169
12345